Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Alves C. Orismilast for moderate-to-severe atopic dermatitis: the potential therapeutic value of a new oral pharmacological alternative. Br J Dermatol 2025 Jan 30:ljaf042. doi: 10.1093.
PMID: 39880395


Privacy Policy